Patients with advanced rectal cancer are typically treated with chemo- and radiation therapy (chemoradiation) followed by a major surgery where the entire rectum is removed. Some patients respond so well to chemoradiation that here is hardly any tumor present after treatment. This is why major surgery is increasingly omitted in patients that respond well to chemoradiation and instead these patients are treated “organ-saving” – i.e. with only a minor intervention or even without surgery. In this thesis, the possibility to predict treatment outcome to chemoradiation beforehand based on the available clinical data and imaging data has been studied using prediction models. If it is known upfront whether a patient will respond well to chemoradia...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...
BACKGROUND AND PURPOSE: To safely implement organ preserving treatment strategies for patients with ...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...
Patients with advanced rectal cancer are typically treated with chemo- and radiation therapy (chemor...
Treatment options for rectal cancer include surgery, radiation therapy and chemotherapy. In recent y...
Purpose: To develop and validate an accurate predictive model and a nomogram for pathologic complete...
Locally advanced rectal cancer is treated with chemotherapy, radiotherapy and surgery. A minority of...
Purpose: To develop a positron emission tomography (PET)-based response prediction model to differen...
Purpose: Personalized treatments based on predictions for patient outcome require early characteriza...
Objectives To explore the value of multiparametric MRI combined with FDG-PET/CT to identify well-res...
Funding Information: This study has received funding from the Dutch Cancer Society (project number 1...
BackgroundRectal cancer has a high prevalence. The standard of care for management of localised dise...
Medical imaging is essential for the diagnosis, treatment and follow-up of patients with cancer. Com...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...
BACKGROUND AND PURPOSE: To safely implement organ preserving treatment strategies for patients with ...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...
Patients with advanced rectal cancer are typically treated with chemo- and radiation therapy (chemor...
Treatment options for rectal cancer include surgery, radiation therapy and chemotherapy. In recent y...
Purpose: To develop and validate an accurate predictive model and a nomogram for pathologic complete...
Locally advanced rectal cancer is treated with chemotherapy, radiotherapy and surgery. A minority of...
Purpose: To develop a positron emission tomography (PET)-based response prediction model to differen...
Purpose: Personalized treatments based on predictions for patient outcome require early characteriza...
Objectives To explore the value of multiparametric MRI combined with FDG-PET/CT to identify well-res...
Funding Information: This study has received funding from the Dutch Cancer Society (project number 1...
BackgroundRectal cancer has a high prevalence. The standard of care for management of localised dise...
Medical imaging is essential for the diagnosis, treatment and follow-up of patients with cancer. Com...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...
BACKGROUND AND PURPOSE: To safely implement organ preserving treatment strategies for patients with ...
Background: Response to neoadjuvant chemoradiotherapy (CRT) of rectal cancer is variable. Accurate i...